The U.S. Supreme Court’s ruling in American Hospital Association (“AHA”) v. Becerra (2022) sent shockwaves through the 340B drug pricing program when it held that CMS’ reduction of reimbursement for drugs purchased under the...more
Knock, knock! If the Drug Enforcement Administration (DEA) is already at your door, it may be too late.
Enforcement is on the rise, and the microscope is fixed on controlled substances. What can industry stakeholders do to...more
On November 3, 2023, the United States District Court for the District of South Carolina issued its decision in the long-running dispute between Genesis Health Care Inc., a federally qualified health center and 340B-covered...more